Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 41, 1329-1333, April 1, 1981]
© 1981 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Abul-Hajj, Y. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Abul-Hajj, Y. J.

Altered Steroid {Delta}4-Reductase Activity in Mammary Tumor-bearing Rats1

Yusuf J. Abul-Hajj

College of Pharmacy, University of Minnesota, Minneapolis, Minnesota 55455

The effect of mammary tumors on steroid {Delta}4-reductase activity was investigated using in vitro and in vivo studies in three transplantable rat mammary tumors. Steroid {Delta}4-5{alpha}-reductase activity was measured spectrophotometrically and was significantly decreased in the host livers from R3230AC and MT/W9a-B but was increased in 7,12-dimethylbenz(a)anthracene-induced No. 14 tumor-bearing rats. There were no significant alterations of 5ß-reductase activity in all animals investigated. In vivo studies using [14C]testosterone showed a similar pattern for saturation of the 4,5-double bond but that the more than doubled increase in 4,5-reduced metabolites observed in the in vivo studies in 7,12-dimethylbenz(a)anthracene-induced tumor-bearing rats cannot be explained by the increase observed in hepatic enzyme activity. Incubations with mammary tumor tissues showed that 7,12-dimethylbenz(a)anthracene-induced tumors have a very active {Delta}4-5{alpha}-reductase enzyme which accounts for the observed increases in in vivo results. The surgical removal of the tumor abolishes the impairment in {Delta}4-reductase activity.

1 These investigations were supported by Grant CA 22467 from the National Cancer Institute, USPHS.

Received 8/22/80. Accepted 1/12/81.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1981 by the American Association for Cancer Research.